Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, et al. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial. Lancet 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921.
PMID: 38768626